PDL BIOPHARMA INC
(69329Y104)
Fonds déclarant des avoirs de PDL BIOPHARMA INC selon 13F dépôts
Nom de l\'entreprise | Actions détenues / capital | Valeur marchande | Option | Période de rapport | Date d\'entrée en vigueur |
---|---|---|---|---|---|
Dupont Capital Management Corp | 309,526 | $972k | Jun 30, 2019 | Jul 30, 2019 | |
Acadian Asset Management LLC | 189,866 | $596k | Jun 30, 2019 | Aug 8, 2019 | |
Crestline Management LP | 150,000 | $471k | Jun 30, 2019 | Aug 13, 2019 | |
QS Investors LLC | 136,330 | $429k | Jun 30, 2019 | Aug 14, 2019 | |
SMH Capital Advisors LLC | 85,368 | $268k | Jun 30, 2019 | Aug 5, 2019 | |
Caxton Associates LP | 83,060 | $261k | Jun 30, 2019 | Aug 14, 2019 |